Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasoactive intracavernous pharmacotherapy.

A A Sidi1

  • 1Department of Urologic Surgery, University of Minnesota Hospital and Clinic, Minneapolis.

The Urologic Clinics of North America
|February 1, 1988
PubMed
Summary

Vasoactive intracavernous pharmacotherapy is an effective impotence treatment with few short-term issues. Careful patient selection and technique are crucial for minimizing complications and monitoring for penile abnormalities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urologic pelvic surgery following mesh hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2009
Same author

Diagnostic value of CT-guided biopsy of indeterminate renal masses.

Clinical radiology·2004
Same author

The effect of pneumoperitoneum on dissemination and scar implantation of intra-abdominal tumor cells.

The Journal of urology·2000
Same author

The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel.

British journal of cancer·2000
Same author

Long-term follow-up of patients receiving injection therapy for erectile dysfunction.

Urology·1997
Same author

Clinical trial of a simplified vacuum erection device for impotence treatment.

Urology·1992

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Vasoactive intracavernous pharmacotherapy is increasingly used for erectile dysfunction.
  • Its effectiveness and low incidence of short-term complications contribute to its expanding use.

Purpose of the Study:

  • To highlight the importance of proper patient selection and technique in intracavernous pharmacotherapy.
  • To outline management strategies for sustained erections and the necessity of monitoring for adverse effects.

Main Methods:

  • Review of current practices and recommendations for vasoactive intracavernous pharmacotherapy.
  • Emphasis on candidate selection, dosage, injection technique, and follow-up protocols.

Main Results:

  • Effective treatment for impotence with a low rate of short-term complications when administered correctly.
  • Sustained erections require prompt treatment with alpha-adrenergic agents.
  • Penile abnormalities necessitate frequent follow-up.

Conclusions:

  • Careful patient selection, dosage, and technique are mandatory to minimize complications.
  • Regular follow-up is essential to detect and manage potential penile abnormalities.
  • Further research is needed to understand long-term adverse effects.

Related Experiment Videos